HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BR96-doxorubicin immunoconjugate

a chimeric monoclonal antibody, BR96 & doxorubicin immunoconjugate developed for the treatment of tumors that express Lewis(y)-related antigens
Also Known As:
BMS 182248; BMS-182248; SNG-15
Networked: 2 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Related Diseases

1. Neoplasms (Cancer)
2. Breast Neoplasms (Breast Cancer)

Related Drugs and Biologics

1. BR96-doxorubicin immunoconjugate
2. Doxorubicin (Adriamycin)
3. Antigens

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)